• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性B细胞在抑制人类炎症性疾病中的免疫耐受作用,重点关注糖尿病。

The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus.

作者信息

Zhang Qi, Liao Jinfeng, Liu Zheng, Song Siyuan, Tian Limin, Wang Yi

机构信息

Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China.

出版信息

Front Immunol. 2025 Apr 30;16:1565158. doi: 10.3389/fimmu.2025.1565158. eCollection 2025.

DOI:10.3389/fimmu.2025.1565158
PMID:40370441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12074967/
Abstract

Regulatory B cells (Bregs) are pivotal modulators of immune tolerance, suppressing inflammation through cytokine secretion and cellular interactions. Their role is particularly significant in inflammatory diseases such as type 1 and type 2 diabetes mellitus (T1DM and T2DM), where immune dysregulation contributes to disease progression. In T1DM, Bregs mitigate β-cell autoimmunity via IL-10 production and FOXP3-mediated pathways, but genetic mutations and dysfunctions in these mechanisms exacerbate autoimmunity. In T2DM, chronic inflammation and metabolic stress impair Breg numbers and function, further fueling insulin resistance. While Bregs play a central role in T1DM by directly preventing β-cell destruction, their role in T2DM is more supportive, modulating inflammation in metabolically stressed tissues. Emerging therapeutic strategies aim to enhance Breg function through IL-10 induction, ex vivo expansion, or targeting Breg-specific pathways using gene-editing and small molecules. Future research should explore Breg heterogeneity, novel markers, and personalized therapies to unlock their full potential. Understanding and leveraging the immune tolerance role of Bregs may offer transformative strategies to inhibit inflammatory diseases like diabetes mellitus.

摘要

调节性B细胞(Bregs)是免疫耐受的关键调节因子,通过细胞因子分泌和细胞间相互作用抑制炎症。它们在1型和2型糖尿病(T1DM和T2DM)等炎症性疾病中的作用尤为重要,在这些疾病中免疫失调会促进疾病进展。在T1DM中,Bregs通过产生IL-10和FOXP3介导的途径减轻β细胞自身免疫,但这些机制中的基因突变和功能障碍会加剧自身免疫。在T2DM中,慢性炎症和代谢应激会损害Bregs的数量和功能,进一步加剧胰岛素抵抗。虽然Bregs通过直接防止β细胞破坏在T1DM中发挥核心作用,但其在T2DM中的作用更具支持性,可调节代谢应激组织中的炎症。新兴的治疗策略旨在通过诱导IL-10、体外扩增或使用基因编辑和小分子靶向Breg特异性途径来增强Breg功能。未来的研究应探索Breg的异质性、新型标志物和个性化疗法,以充分发挥其潜力。了解并利用Bregs的免疫耐受作用可能会为抑制糖尿病等炎症性疾病提供变革性策略。

相似文献

1
The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus.调节性B细胞在抑制人类炎症性疾病中的免疫耐受作用,重点关注糖尿病。
Front Immunol. 2025 Apr 30;16:1565158. doi: 10.3389/fimmu.2025.1565158. eCollection 2025.
2
Regulatory B Cells in Autoimmune Diabetes.自身免疫性糖尿病中的调节性 B 细胞。
J Immunol. 2021 Mar 15;206(6):1117-1125. doi: 10.4049/jimmunol.2001127.
3
The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus.IL-35 在 1 型糖尿病病理生理过程中的潜在治疗作用。
Cytokine. 2024 Oct;182:156732. doi: 10.1016/j.cyto.2024.156732. Epub 2024 Aug 9.
4
Regulatory B Cells: Role in Type 1 Diabetes.调节性 B 细胞:在 1 型糖尿病中的作用。
Front Immunol. 2021 Sep 20;12:746187. doi: 10.3389/fimmu.2021.746187. eCollection 2021.
5
Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.白细胞介素-10+调节性B细胞在经历抗原刺激的CD40+B细胞中产生,以维持对胰岛自身抗原的耐受性。
Diabetes. 2015 Jan;64(1):158-71. doi: 10.2337/db13-1639. Epub 2014 Sep 3.
6
Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes.1 型糖尿病调节性 B 细胞亚群中 Tim-1 和 IL-10 表达的改变。
Front Immunol. 2021 Dec 21;12:773896. doi: 10.3389/fimmu.2021.773896. eCollection 2021.
7
Ex vivo-generated human CD1c regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host disease.通过化学限定系统体外生成的人CD1c调节性B细胞可抑制免疫反应并减轻移植物抗宿主病。
Mol Ther. 2024 Dec 4;32(12):4372-4382. doi: 10.1016/j.ymthe.2024.10.026. Epub 2024 Oct 26.
8
Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway.梓醇联合脂多糖通过 STAT3 信号通路诱导产生白细胞介素-10 的调节性 B 细胞。
Biomed Pharmacother. 2020 Sep;129:110450. doi: 10.1016/j.biopha.2020.110450. Epub 2020 Jul 7.
9
Interleukin 35 Regulatory B Cells.白细胞介素 35 调节性 B 细胞。
J Mol Biol. 2021 Jan 8;433(1):166607. doi: 10.1016/j.jmb.2020.07.019. Epub 2020 Aug 2.
10
The characteristic activity of regulatory B cells during the occurrence and development of insulin resistance.调节性B细胞在胰岛素抵抗发生发展过程中的特征性活性。
Endocrine. 2025 Feb;87(2):562-568. doi: 10.1007/s12020-024-04040-7. Epub 2024 Sep 23.

引用本文的文献

1
The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches.原发性免疫性血小板减少症(ITP)中的肠道-免疫轴:治疗方法的范式转变
Front Immunol. 2025 Jun 12;16:1595977. doi: 10.3389/fimmu.2025.1595977. eCollection 2025.

本文引用的文献

1
A systematic review on gut microbiota in type 2 diabetes mellitus.关于2型糖尿病肠道微生物群的系统评价。
Front Endocrinol (Lausanne). 2025 Jan 17;15:1486793. doi: 10.3389/fendo.2024.1486793. eCollection 2024.
2
The role of B cells in the pathogenesis of type 1 diabetes.B细胞在1型糖尿病发病机制中的作用。
Front Immunol. 2024 Dec 24;15:1450366. doi: 10.3389/fimmu.2024.1450366. eCollection 2024.
3
Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes.探索脂肪酸、炎症与2型糖尿病之间的相互作用。
Immuno. 2024 Mar;4(1):91-107. doi: 10.3390/immuno4010006. Epub 2024 Mar 1.
4
Expanding Human Breg for Cellular Therapy in Transplantation: Time for Translation.拓展人类调节性B细胞用于移植中的细胞治疗:转化时机已至。
Transplantation. 2025 Jun 1;109(6):926-937. doi: 10.1097/TP.0000000000005243. Epub 2024 Oct 23.
5
CD19: a promising target for systemic sclerosis.CD19:系统性硬化症的一个有前途的靶点。
Front Immunol. 2024 Oct 3;15:1454913. doi: 10.3389/fimmu.2024.1454913. eCollection 2024.
6
The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus.胰岛自身抗原特异性 T 细胞在 1 型糖尿病发病和治疗中的作用。
Front Immunol. 2024 Sep 24;15:1462384. doi: 10.3389/fimmu.2024.1462384. eCollection 2024.
7
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.免疫系统的代谢调控在健康和疾病中的作用:机制与干预措施。
Signal Transduct Target Ther. 2024 Oct 9;9(1):268. doi: 10.1038/s41392-024-01954-6.
8
The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).目前对人类调节性B细胞(Bregs)的表型和功能特性的理解。
Oxf Open Immunol. 2024 Sep 20;5(1):iqae012. doi: 10.1093/oxfimm/iqae012. eCollection 2024.
9
IL-35 promotes IL-35IL-10 Bregs and Conventional LAG3 Tregs in the lung tissue of OVA-Induced Asthmatic Mice.IL-35 在 OVA 诱导的哮喘小鼠肺组织中促进 IL-35IL-10 Bregs 和常规 LAG3 Tregs 的产生。
Inflamm Res. 2024 Oct;73(10):1699-1709. doi: 10.1007/s00011-024-01925-1. Epub 2024 Aug 10.
10
Fatty acid oxidation in immune function.脂肪酸在免疫功能中的氧化作用。
Front Immunol. 2024 Jun 27;15:1420336. doi: 10.3389/fimmu.2024.1420336. eCollection 2024.